Gram Negative Infections: Clinical Trials

1 trial for Gram Negative Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Gram Negative Infections: new trials by email Literature Review of Gram Negative Infections trials Research Report on Gram Negative Infections

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections
Ceftazidime± avibactam with fosfomycin, Ceftazidime± avibactam with placebo - Gram Negative Infections, Sepsis and Septic Shock
Phase 3RecruitingAngela HUTTNER1002025-08-252025-09-26

Narrower conditions

Sepsis (1)  ·  Shock, Septic (1)

Broader conditions

Infections (1)  ·  Inflammation (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Shock (1)  ·  Systemic Inflammatory Response Syndrome (1)

Interventions

Fosfomycin (1)  ·  avibactam, ceftazidime drug combination (1)

Sponsors

Angela HUTTNER (1)

Countries

Switzerland (1)